External quality assessment scheme for Neisseria meningitidis - 2014
ECDC promotes the performance of external quality assessment schemes, under which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine and/or reference laboratory methods.
In July 2014, a panel of two viable isolates of N. meningitidis of the major disease-causing serogroups with three simulated cerebrospinal fluid (non-culture) samples for molecular studies, was sent by UK NEQAS to 30 reference laboratories in the IBD-labnet surveillance network for quality assessment testing. This report summarises the diagnostic results submitted by the participating laboratories.
The main purposes of external quality assessment schemes are as follows:
- assessment of the general standard of performance (‘state of the art’)
- assessment of the effects of analytical procedures (method principle, instruments, reagents, calibration)
- evaluation of individual laboratory performance
- identification and justification of problem areas
- provision of continuing education
- identification of needs for training activities.
Proficiency test for Listeria monocytogenes whole genome assembly 2018
16 May 2019 - This report presents the results of a proficiency test to evaluate the inter-laboratory reproducibility and portability of Listeria monocytogenes (Lm) genome assemblies in the EU/EEA.
Laboratory testing of non-partner sperm donors
20 Jun 2018 - The European Centre for Disease Prevention and Control was asked by the European Commission to assess the risk involved in changing the testing requirements for HIV (human immunodeficiency virus), hepatitis B virus (HBV), and hepatitis C virus (HCV) with regard to the quality and safety of non-partner semen donations.
EU Laboratory Capability Monitoring System (EULabCap): Report on 2016 survey of EU/EEA country capabilities and capacities
2 May 2018 - This report for 2016, which presents the indicator results for EU and EEA (European Economic Area) countries, aims to help policymakers identify possible areas for action and to evaluate the impact of capacity strengthening activities and health system reforms.